MaxCyte, Inc.
NASDAQ:MXCT
3.77 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 41.288 | 44.262 | 33.894 | 26.169 | 21.621 | 16.667 | 13.985 | 12.27 | 9.29 | 7.164 | 6.805 | 5.06 |
| Cost of Revenue
| 8.727 | 5.098 | 3.647 | 2.767 | 2.499 | 1.84 | 1.453 | 1.308 | 1.032 | 0.958 | 0.809 | 0.83 |
| Gross Profit
| 32.561 | 39.163 | 30.247 | 23.402 | 19.122 | 14.827 | 12.532 | 10.962 | 8.259 | 6.207 | 5.996 | 4.229 |
| Gross Profit Ratio
| 0.789 | 0.885 | 0.892 | 0.894 | 0.884 | 0.89 | 0.896 | 0.893 | 0.889 | 0.866 | 0.881 | 0.836 |
| Reseach & Development Expenses
| 23.817 | 19.514 | 15.407 | 17.744 | 17.601 | 11.244 | 11.285 | 4.696 | 3.008 | 2.49 | 2.216 | 2.207 |
| General & Administrative Expenses
| 30.068 | 25.829 | 18.676 | 8.386 | 6.088 | 5.284 | 4.522 | 4.205 | 2.667 | 2.468 | 2.212 | 2.022 |
| Selling & Marketing Expenses
| 26.975 | 18.653 | 13.003 | 8.329 | 7.852 | 6.724 | 6.017 | 4.784 | 3.344 | 2.524 | 2.374 | 1.963 |
| SG&A
| 56.959 | 44.482 | 31.679 | 16.714 | 13.94 | 12.008 | 10.539 | 8.989 | 6.012 | 4.992 | 4.586 | 3.985 |
| Other Expenses
| 3.985 | 2.528 | 1.349 | 0 | 0 | 0 | 0 | 0.016 | 0.02 | 0 | 0 | 0 |
| Operating Expenses
| 80.776 | 66.524 | 48.435 | 34.459 | 31.542 | 23.252 | 21.824 | 13.685 | 9.02 | 7.483 | 6.801 | 6.192 |
| Operating Income
| -48.215 | -27.361 | -18.189 | -11.057 | -12.42 | -8.425 | -9.292 | -2.723 | -0.761 | -1.276 | -0.805 | -1.963 |
| Operating Income Ratio
| -1.168 | -0.618 | -0.537 | -0.423 | -0.574 | -0.505 | -0.664 | -0.222 | -0.082 | -0.178 | -0.118 | -0.388 |
| Total Other Income Expenses Net
| 10.292 | 3.79 | -0.894 | -0.76 | -0.475 | -0.444 | -0.625 | 0.016 | 0.02 | -0.561 | -0.154 | -0.026 |
| Income Before Tax
| -37.923 | -23.571 | -19.082 | -11.816 | -12.895 | -8.869 | -9.917 | -3.346 | -1.446 | -1.837 | -0.958 | -1.988 |
| Income Before Tax Ratio
| -0.918 | -0.533 | -0.563 | -0.452 | -0.596 | -0.532 | -0.709 | -0.273 | -0.156 | -0.256 | -0.141 | -0.393 |
| Income Tax Expense
| 4.003 | -3.79 | 1.044 | 0.826 | 0.681 | 0.17 | 0 | 0.654 | 0.724 | 0 | 0 | 0.036 |
| Net Income
| -37.923 | -19.781 | -20.127 | -12.642 | -13.576 | -8.869 | -9.917 | -3.346 | -1.446 | -1.837 | -0.958 | -1.988 |
| Net Income Ratio
| -0.918 | -0.447 | -0.594 | -0.483 | -0.628 | -0.532 | -0.709 | -0.273 | -0.156 | -0.256 | -0.141 | -0.393 |
| EPS
| -0.37 | -0.19 | -0.22 | -0.18 | -0.24 | -0.17 | -0.2 | -0.1 | -0.033 | -0.042 | -0.022 | -0.046 |
| EPS Diluted
| -0.37 | -0.19 | -0.22 | -0.18 | -0.24 | -0.17 | -0.2 | -0.1 | -0.033 | -0.042 | -0.022 | -0.046 |
| EBITDA
| -44.044 | -20.746 | -16.614 | -9.943 | -11.6 | -7.911 | -9.149 | -2.602 | -0.648 | -1.184 | -0.688 | -1.812 |
| EBITDA Ratio
| -1.067 | -0.469 | -0.49 | -0.38 | -0.537 | -0.475 | -0.654 | -0.212 | -0.07 | -0.165 | -0.101 | -0.358 |